Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Terminal hydroxyethyl substituent
What ifWhat if the ring nitrogen carries a terminal 2-hydroxyethyl group?
Claim language“a terminal hydrocarbon group”
The ring nitrogen bonds to the first carbon of the two-carbon chain, and a hydroxyl group bonds to the second carbon. The hydroxyl group remains neutral in mildly acidic water, where a chloride-form anion-exchange resin replaces the bromide counterion.
1.2Sulfur bridge between ring nitrogens
What ifWhat if a thioether bridge joins the two pyridinium ring nitrogens?
Claim language“a hydrocarbon linking group R4”
The bridge places sulfur between two ethylene segments, with one segment attached to each ring nitrogen. The linked ring nitrogens carry two positive charges, and a chloride-form resin exchanges the two bromide counterions for chloride.
1.2Diamide bridge between ring nitrogens
What ifWhat if a bridge containing two amide bonds joins the two pyridinium ring nitrogens?
Claim language“a hydrocarbon ether linking group”
A succinamide unit with a two-carbon arm on each amide nitrogen connects the two pyridinium rings through their ring nitrogens. The amide groups remain neutral in water while a chloride-form resin exchanges the counterions of the linked dication.
1.2Bromide precipitation during chloride exchange
What ifWhat if silver bromide precipitation drives counterion exchange while the oxime stays protonated?
Claim language“a zwitterionic intermediate”
Freshly precipitated silver chloride supplies chloride when mixed with an aqueous pyridinium oxime bromide solution. Silver bromide forms as a less soluble solid, and filtration separates the silver halide solids from the pyridinium oxime chloride solution.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Counterion series for crystal growth studies
A materials chemistry laboratory uses one batch of a monocationic pyridinium oxime to compare crystal growth across counterions. The laboratory deprotonates the oxime, separates the zwitterion from the original counterion, and divides the intermediate into equal molar portions. Each portion receives one molar equivalent of formic, acetic, or lactic acid. The resulting salts undergo slow evaporation at the same temperature, and powder X-ray diffraction distinguishes the crystalline phases.
Component substitution
Hydroxide resin forms the zwitterion
A packed bed of strongly basic anion exchange resin in the hydroxide form supplies the base for oxime deprotonation. An aqueous solution of the starting pyridinium oxime salt passes through the bed, where the resin captures the original anion and released hydroxide deprotonates the oxime. The effluent and a water rinse carry the zwitterionic intermediate into a separate vessel, where acetic acid protonates the oximate and supplies acetate.
Lactic acid supplies the counterion
A stirred vessel holds an aqueous solution of the separated zwitterion from a monocationic pyridinium oxime. A metering pump adds one mole of lactic acid per mole of zwitterion. The acid protonates the oximate oxygen and supplies lactate as the counterion. Reduced-pressure evaporation concentrates the solution for isolation of the lactate salt.
Parameter or scale variation
Parallel conversion at millimole scale
A rack holds six 20 mL vials, each containing 0.50 mmol of a separated monocationic pyridinium oxime zwitterion in 10 mL of water. Each vial receives 0.50 mL of 1.0 M acetic acid under magnetic stirring at 20 to 25 °C. The vials stir for 10 minutes, and ion chromatography measures acetate and residual starting anion in each vial before concentration.
Combination with existing systems
Inline acidification with membrane concentration
A static mixer combines a stream of separated aqueous zwitterion with an acetic acid stream metered at one mole per mole of monocationic zwitterion. The mixer outlet feeds a recirculating reverse-osmosis module whose membrane retains the dissolved pyridinium salt. The module removes water as permeate and returns the retentate to a concentration tank until the tank reaches its target volume. Ion chromatography measures acetate in the retentate before product collection.
Automated or data-driven variant
Spectroscopic control of acid dosing
A stirred reactor holds the separated zwitterion and connects to a recirculating ultraviolet-visible flow cell and a programmable acid pump. Calibration solutions of the zwitterion and the protonated pyridinium oxime acetate provide reference spectra at the operating concentration. The controller estimates the remaining oximate fraction after each acetic acid increment and reduces the increment size as that fraction falls. The controller ends dosing when the estimated fraction reaches the preset endpoint in two consecutive readings.
Specific version of a part
Methyl at the first position
The ring methyl group is a spectator substituent during counterion exchange. A chloride-form anion-exchange resin captures bromide from the dissolved pyridinium oxime salt and releases chloride.
N-ethyl pyridinium aldoxime bromide
The pyridinium ring carries an aldoxime at the carbon adjacent to the ring nitrogen. An ethyl group bonds to the ring nitrogen, and one bromide counterion balances the positive charge.
Ether bridge between oxime rings
A bridge with two methylene groups on each side of an ether oxygen connects the two pyridinium ring nitrogens. Each ring bears an aldoxime, and two bromide ions balance the charge of the linked cation.
Chloride formation by oximate protonation
A hydroxide-form anion-exchange resin takes up bromide and supplies hydroxide, which removes the proton from the aldoxime oxygen. The resulting zwitterion contains a positively charged ring nitrogen and a negatively charged oximate oxygen. Aqueous hydrochloric acid protonates the oximate oxygen and supplies chloride as the counterion.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1a. providing a first pyridinium oxime salt having the following structure: wherein A1− comprises a first anionic group, R1 comprises a hydrogen or oxime group, R2 comprises a hydrogen or oxime group and R3 comprises one of: (1) a terminal hydrocarbon group
A method of forming bis-quaternary pyridinium oximes comprising: supplying benzoic anhydride having the following structure: reacting said benzoic anhydride with trioxane to form a dibenzoyloxymethyl ether having the following structure: supplying a substituted pyridine having the following structure: wherein R1 and R2 may be independently selected from the group consisting of consisting of hydrogen, alkyl, —CH═NOH or —CONH2; combining said dibenzoyloxymethyl ether with said
B · US 10,633,340 B1 · claim 1
1.2or (2) a hydrocarbon linking group R4 connected to the nitrogen atom of a second pyridinium oxime as in the following: (3) a hydrocarbon ether linking group (—R5—O—R5—) where R5 is a hydrocarbon connected to the nitrogen atom of a second heterocyclic ring nitrogen atom as in one of the following b. transforming said first pyridinium oxime salt into a zwitterionic intermediate and treating said zwitterionic intermediate with a proton acid HA2 where H is a hydrogen and A2 forms a second anionic group A2− thereby providing a second pyridinium oxime salt having one of the following structures: wherein A2− comprises an anionic group that is different from the first anionic group Ar.
A method for preparing a bis-quaternary pyridinium-2-aldoxime salt comprising supplying pyridine-4-aldoximine of the formula: treating said pyridine-4-aldoximine with diodomethane to form 1,1′-methylenebis[4-[(hydroxyimino)methyl]-pyridinium] diodide of the following formula: converting said 1,1′-methylenebis [4-[(hydroxyimino)methyl]-pyridinium] diodide to the following structure via ion exchange of the iodine to provide the following bis-quaternary pyridinium-2-aldoxime sal
A · US 8,404,850 B2 · claim 17
An empty cell means only that no passage was reproduced there.
Statements in these documents
The present invention relates to bis-quaternary pyridinium-aldoxime salts, their associated methods of preparation including their use for treatment of exposure to cholinesterase inhibitors, such as a phosphorous containing cholinesterase inhibitor type compounds.
A · US 8,404,850 B2 · ¶ 2
Accordingly, if an individual is regularly exposed to such inhibitors, there remains a need to prophylactically or therapeutically treat such toxicity.
A · US 8,404,850 B2 · ¶ 3
The present invention relates to a synthetic route to bis-quaternary pyridinium oximes which can be utilized to restore activity of acetylcholinesterase inhibited by combination with organophosphates.
B · US 10,633,340 B1 · ¶ 1
However, current methods to synthesize the above referenced antidotes require the use of chemical compounds which are extremely toxic and which lead to relatively large amounts of side products that are difficult to remove from the reaction media.
B · US 10,633,340 B1 · ¶ 4
Cite aspatent.fyi, US 2026/0356802 A1, claim 1, first published 2026-11-20T07:31:16-05:00, https://patent.fyi/US20260356802/, SHA-256 e85f3869d45b44743c2c074c76d660cfda7f4dee9225dca192d511e9855a4b9f